Company / Free Cash Flow
Niagen Bioscience, Inc. Free Cash Flow History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$21.2M
FY2019
5-year range
-
FY2016-FY2019
Trend
-93.1%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$11M to -$21M over the past 2 years.
Based on SEC 10-K filings.
-$21M in FY2019.
Declined from -$11M to -$21M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, free cash flow decreased 93.1% year-over-year.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | -$21.2M | -93.1% |
| FY2018 | -$11.0M | +0.0% |
| FY2017 | -$11.0M | -147.0% |
| FY2016 | -$4.4M | -68.5% |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026